ArticleCancer research2017

Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer.

Suriyan Ponnusamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.